Your browser doesn't support javascript.
loading
The benefits of COVID lockdowns on respiratory health: What factors may have contributed to the decline in hospital admissions for cystic fibrosis?
Robey, Rebecca C; Crozier, Orlagh; Frame, Arran; Martin, Katrina; Ashcroft, Philip; Iqbal, Nizhat; Barry, Peter J; Jones, Andy; Ahmad, Shazaad; Horsley, Alexander.
Affiliation
  • Robey RC; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, UK; The North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: Rebe
  • Crozier O; The University of Manchester Medical School, The University of Manchester, Oxford Road, Manchester, UK.
  • Frame A; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Martin K; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Ashcroft P; Department of Virology, Manchester Medical Microbiology Partnership, Manchester University NHS Foundation Trust, Manchester, UK.
  • Iqbal N; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Barry PJ; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, UK; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Jones A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, UK; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Ahmad S; Department of Virology, Manchester Medical Microbiology Partnership, Manchester University NHS Foundation Trust, Manchester, UK.
  • Horsley A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, UK; Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Respir Med Res ; 84: 101061, 2023 Nov.
Article de En | MEDLINE | ID: mdl-38029649
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mucoviscidose / Polluants atmosphériques / COVID-19 Limites: Humans Langue: En Journal: Respir Med Res Année: 2023 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mucoviscidose / Polluants atmosphériques / COVID-19 Limites: Humans Langue: En Journal: Respir Med Res Année: 2023 Type de document: Article